Abstract
Objective Empowerment impacts reproductive health behaviors profoundly. Similarly, contraceptive access and use result in broader social and economic opportunities. We aimed to quantify the directionality of this cyclical relationship.
Study design This study utilizes data from the Performance Monitoring for Action (PMA) surveys in Kenya, Nigeria (Kano), Burkina Faso, Democratic Republic of Congo (DRC), and Uganda. Using annual longitudinal data (2019-2021), we employed cross-lagged panel models (CLPM) to analyze the bidirectional relationship between women’s empowerment and contraceptive use.
Results There was a significant positive impact of contraceptive use on women’s empowerment. In Kenya and Kano, contraceptive use was associated with a 10.1% and 12.0% increase in paid work and 14.5% and 14.8% greater control over wages, respectively. In Kenya, women doing paid work with wage control were 5.2% more likely to use contraception the following year. In Kano, control over partner’s wages increased contraceptive use by 9.6%. Additionally, having savings, financial goals, increased financial autonomy, and knowledge of financial information were associated with higher future contraceptive use.
Conclusions Contraceptive use can act as a catalyst for empowerment, while empowerment, particularly decision-making autonomy over finances, enhances contraceptive use. However, these dynamics vary across different settings, emphasizing the need for context-specific strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are publicly available.
